Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
about
Toll-Like Receptors in the Pathogenesis of Autoimmune DiseasesMiddle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak controlHost innate immune responses to sepsisMultiple roles of toll-like receptor 4 in colorectal cancerEBI2 is a negative regulator of type I interferons in plasmacytoid and myeloid dendritic cellsStructure and dynamic behavior of Toll-like receptor 2 subfamily triggered by malarial glycosylphosphatidylinositols of Plasmodium falciparumAn anti-inflammatory NOD-like receptor is required for microglia developmentEffect of Kangshuanyihao Formula on the Inflammatory Reaction and SIRT1/TLR4/NF-κB Signaling Pathway in Endothelial Injury.Live Combined Bacillus subtilis and Enterococcus faecium Ameliorate Murine Experimental Colitis by ImmunosuppressionAnti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways.The effects of the microbiota on the host immune system.Dynamic Arginine Methylation of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6 Regulates Toll-like Receptor Signaling.The Arabidopsis Protein Phosphatase PP2C38 Negatively Regulates the Central Immune Kinase BIK1.Activating transcription factor 3 represses inflammatory responses by binding to the p65 subunit of NF-κBA herbal formula comprising Rosae Multiflorae Fructus and Lonicerae Japonicae Flos, attenuates collagen-induced arthritis and inhibits TLR4 signalling in rats.Toll-like receptors in atherosclerosisInterplay of Toll-Like Receptor 9, Myeloid Cells, and Deubiquitinase A20 in Periodontal Inflammation.Porcine Reproductive and Respiratory Syndrome Virus nsp1α Inhibits NF-κB Activation by Targeting the Linear Ubiquitin Chain Assembly Complex.Resveratrol mitigates lipopolysaccharide-mediated acute inflammation in rats by inhibiting the TLR4/NF-κBp65/MAPKs signaling cascade.Collaborative action of Toll-like and NOD-like receptors as modulators of the inflammatory response to pathogenic bacteria.Bombyx mori hemocyte extract has anti-inflammatory effects on human phorbol myristate acetate-differentiated THP‑1 cells via TLR4-mediated suppression of the NF-κB signaling pathway.Advances in Antiviral Therapies Targeting Toll-like Receptors.Toll-like receptors: promising therapeutic targets for inflammatory diseases.Anti-inflammatory potential of newly synthesized 4-[(butylsulfinyl)methyl]-1,2-benzenediol in lipopolysaccharide-stimulated BV2 microglia.Toll-like receptors targeting technology for the treatment of lymphoma.Emerging roles of orphan nuclear receptors in regulation of innate immunity.Anaphylatoxin C5a Regulates 6-Sulfo-LacNAc Dendritic Cell Function in Human through Crosstalk with Toll-Like Receptor-Induced CREB Signaling.Triggering receptor expressed on myeloid cells-2 fine-tunes inflammatory responses in murine Gram-negative sepsis.The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-κB.Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson's disease.Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.Simultaneous quantitation and validation of triterpenoids and phytosteroids in Phaseolus angularis seeds.Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus?PLAP-1/Asporin Regulates TLR2- and TLR4-induced Inflammatory Responses.RAGE and TLRs as Key Targets for Antiatherosclerotic Therapy
P2860
Q26770257-DBDABA5C-18C6-4844-A4F0-E0CC5C338239Q26796501-8236128D-08CC-4271-AF58-132C8EDE5041Q26864635-560542CD-555C-4F1C-AEED-7A9DFCD04034Q27008380-64A23B4B-FE76-4B7F-8670-2C05E92599A6Q27339798-352BE22B-E575-40AC-93ED-6EF536BE024DQ28299735-EB689D02-3D09-4A0F-A0BD-38C38F184B85Q28393591-0364BFD3-5850-467A-9D13-76B92B0A265EQ33678885-1EC8D527-5FA0-494D-B32F-3E0EDCF243C3Q34222447-A0C7ABBE-F62C-4005-9EA6-F6918F9DB5F0Q34386876-6477D2D0-86A1-473A-8C66-EC57A9EA8D3CQ35206226-21D74062-E147-4A24-BBF0-C097C18A8AB4Q36065272-BC2CBE0F-DF46-4D99-B0F7-C14DEA9E9D6FQ36096103-7167E192-8E92-49F3-B3FB-07C07F52641CQ36100176-3983FBB8-B6E2-4930-B0E1-70CA6961296BQ36564937-AC6C52A6-9E6D-4169-9C10-9843D3519E1BQ37091891-9B38565D-EC83-49D8-8B89-135F6A121211Q37547012-853D77D3-8BBF-41C5-8DD2-F456F291FE33Q37593192-961B8969-4035-40B1-A6D1-85BD390985FCQ37712915-E77C3D21-A095-499A-B4AE-7D9960BED123Q38294397-5C130B14-6DF9-4DB7-9159-7AB74984BAFBQ38695927-C8C9CC8A-195B-4655-AD16-EAB6A07C9DB0Q38733975-252F18B0-7F1E-4B46-A126-B60E96A19455Q38925152-60210EB0-AAF7-4329-8479-3461EE6906F5Q38947251-0D0CFBB2-8096-4CC9-A289-FFC81F972B26Q38948266-CA035283-2348-4A2A-9AD2-477CB30258E4Q38971639-45DED0D7-221E-42DA-B7C3-6A94D8D2F613Q41010630-58D8181F-EA9B-4C42-A226-6828E719A5D8Q41616021-27B6A34D-E4D2-46EC-BDF9-8E8DA270D2ACQ43416524-E50964D9-0550-447A-9260-E65AE1D572FBQ46465276-A81C299D-1AA9-4E73-A938-6B1DE9EDB582Q47250120-30D789A6-AF2B-457D-85DC-5960FA2BD26DQ50426329-44D545C1-10CC-4C9C-ACE2-E96F71DA4319Q53244774-35162C73-4D43-4203-B47C-A92A03812C88Q54244545-4F1B687A-0761-48F3-A0C8-C25FD65225B6Q58702074-5C2000FD-CEA2-4870-8C73-8F309552DA80
P2860
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
@ast
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
@en
type
label
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
@ast
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
@en
prefLabel
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
@ast
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
@en
P2093
P2860
P921
P356
P1476
Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
@en
P2093
Muhammad Ayaz Anwar
Sangdun Choi
Shaherin Basith
P2860
P2888
P356
10.1038/EMM.2013.28
P577
2013-02-22T00:00:00Z